𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sulphasalazine use as a preventive factor for colorectal cancer in ulcerative colitis patients—a review

✍ Scribed by Dr. Anders Ekbom; Dan Kornfeld

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
344 KB
Volume
2
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of plasma MMP-2 and MMP-9 levels as
Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients
✍ Matthew G. Tutton; Mark L. George; Suzanne A. Eccles; Sarah Burton; R. Ian Swift 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 203 KB 👁 1 views

Matrix metalloproteinases, and notably the gelatinases MMP-2 and MMP-9, have important roles in tumour invasion, metastasis and angiogenesis. Our study investigates the distribution of MMP-2 and MMP-9 in colorectal cancer, the correlation with plasma levels, changes following surgical resection and

Safety and tolerability of a modified fi
Safety and tolerability of a modified filter-type device for leukocytapheresis using ACD-A as anticoagulant in patients with mild to moderately active ulcerative colitis. Results of a pilot study
✍ Vladislaw Muratov; Joachim Lundahl; Aleksandra Mandic-Havelka; Kerstin Elvin; Åk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Cellsorba™ is a medical device for leukocytapheresis (LCAP) treatment of ulcerative colitis (UC). Cellsorba™ EX Global type has been developed from Cellsorba E for intended use with ACD‐A as anticoagulant. We evaluated safety and efficacy of the modified Cellsorba using ACD‐A in a pilot